Earnings Feed
Start Free
Home/Filings/4/0001127602-23-022036
4//SEC Filing

Clark James David 4

Accession 0001127602-23-022036

CIK 0000064803other
View on SEC.govCompany Profile

Filed

Aug 3, 8:00 PM ET

Accepted

Aug 4, 5:41 PM ET

Size

16.6 KB

Accession

0001127602-23-022036

Insider Transaction Report

Form 4
Period: 2023-08-03
CVS HEALTH CorpCVS
Clark James David
SVP, Cont & Chief Acct Officer
Transactions
  • Sale

    Common Stock

    2023-08-03$74.79/sh−2,631.255$196,792→ 27,826 total
  • Sale

    Common Stock

    2023-08-03$74.94/sh−23,128$1,733,212→ 4,698 total
Holdings

  • Common Stock (Restricted)

    8,882

  • Stock Option

    Exercise: $78.05From: 2018-04-03Exp: 2024-04-03→ Common Stock (9,050 underlying)
    9,050

  • Stock Option

    Exercise: $54.19From: 2020-04-01Exp: 2029-04-01→ Common Stock (24,240 underlying)
    24,240

  • Stock Option

    Exercise: $58.34From: 2021-04-01Exp: 2030-04-01→ Common Stock (17,157 underlying)
    17,157

  • Stock Option

    Exercise: $74.30From: 2022-04-01Exp: 2031-04-01→ Common Stock (12,094 underlying)
    12,094

  • Stock Option

    Exercise: $101.09From: 2023-04-01Exp: 2032-04-01→ Common Stock (6,756 underlying)
    6,756

  • Stock Option

    Exercise: $62.21From: 2019-04-01Exp: 2025-04-01→ Common Stock (7,513 underlying)
    7,513

  • Stock Option

    Exercise: $74.31From: 2024-04-01Exp: 2033-04-01→ Common Stock (9,649 underlying)
    9,649
Footnotes (10)
  • [F1]Weighted average sales price; shares sold at a range of 74.79 to 74.80 per share.
  • [F10]Option becomes exercisable in four equal annual installments, commencing 4/1/2024.
  • [F2]Weighted average sales price; shares sold at a range of 74.90 to 75.02 per share.
  • [F3]Options became exercisable in four equal annual installments beginning on 4/3/2018.
  • [F4]Options became exercisable in four equal annual installments, commencing 4/1/2019.
  • [F5]Options became exercisable in four equal annual installments, commencing 4/1/2020.
  • [F6]The number of shares subject to the option were calculated using a 30-day average price.
  • [F7]Options became exercisable in four equal annual installments, commencing 4/1/2021.
  • [F8]Option became exercisable in four equal annual installments, commencing 4/1/2022.
  • [F9]Option became exercisable in four equal installments, commencing 4/1/2023.

Documents

1 file

Issuer

CVS HEALTH Corp

CIK 0000064803

→
Entity typeother

Related Parties

1
  • filerCIK 0001757584

Filing Metadata

Form type
4
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 5:41 PM ET
Size
16.6 KB
View on SEC.gov